Plné znění - 2/2008 Sb. m. s.

Ministerstvo zahraničních xxxx xxxxxxx, xx xxx 16. listopadu 2007 xxxx xxxxxxxxxx xxxxxxxxx XXXXXX, xxxxxxxxxxx Xxxxxxxxxxx úmluvy proti xxxxxxx ve xxxxxx¹⁾, xxxxxxxx xxxxxxxxx xxxxxx xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx látek x metod xxxxxxx.

Xxxxxxx I vstoupila x platnost x xxxxxxx x článkem 34 xxxx. 3 Xxxxxx xxx 1. ledna 2008 x xxxxx xxxx xxxxxxxxx v xxxxxxxx x pro Xxxxxx xxxxxxxxx. Xxxx xxxxxx Xxxxxxx X x xxxxxxxx přestává xxxxxx Xxxxxxx X Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx sportu xx znění pro xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. x. x.

Xxxxxxxx xxxxx Xxxxxxx X a její xxxxxxx do xxxxxxx xxxxxx se xxxxxxxxx xxxxxxxx.

X1. XXXXXXXXXX XXXXX

Xxxxxxxxxx xxxxx xxxx xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX XXXXXXXX (XXX):

x. Exogenní * XXX, zahrnující:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-xxxxxxxxxxxxxxxx); xxxxxxxxxx; xxxxxxxx; boldion (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxx-5α-xxxxxxx-2-xx-17β-xx); xxxxxxxxxxx; xxxxxxxxxxxxx (19-xxx-17α-xxxxx-4-xx-17-xx); xxxxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); xxxxxxxxx; 4-hydroxytestosteron (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; klostebol; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9-dien-3-on); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx); xxxxxxxxxxxxxxxxx; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; xxxxxxxxxxxxxx; xxxxxxxxxxxx; xxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx; oxymetolon; prostanozol ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); quinbolon; stanozolol; xxxxxxxxx; 1-xxxxxxxxxxx (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); xxxxxxxxx x xxxxx látky x podobnou xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.

x. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (androst-5-en-3β,17β-diol), androstendion (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX), xxxxxxxxxxx x xxxxxxxxxxx xxxxxxxxxx x isomery:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)

5α-androstan-3β,17α-diol 5-androstendion (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17β-xxxx

X xxxxxxxxx, kdy může xxxx produkovat xxxxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxxx, xxxx xx xxx xx to, že Xxxxxx obsahuje xxxx Xxxxxxxxx xxxxx x xxxx hlášen xxxxxxxxx Xxxxxxxxx laboratorní nález, xxxx se koncentrace Xxxxxxxx xxxxx nebo xxxxxx metabolitů xxxx xxxxxxxxxxx x/xxxx když xx jakýkoli xxxx xxxxxxxxx xxxxx xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx xxxxxx, které xx xxxxxxxx vyskytují x xxxx xxx, xx xxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx. Xxxxxx xx xxx za to, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx v xxxxxxx xxxxxxx, xxxxx Xxxxxxxxx xxxxxxx, že xx xxxxxxxxxxx Zakázané xxxxx xxxx xxxxxx xxxxxxxxxx nebo xxxxxxxxxx x/xxxx xxxxxxxxx poměr xx Vzorku Xxxxxxxxx xxxxxxxx fyziologickým nebo xxxxxxxxxxxx stavem.

Xxxx xx xxx xx xx, že Vzorek Xxxxxxxxx obsahuje Xxxxxxxxx xxxxx x laboratoř xxxxxxx Pozitivní xxxxxxxxxxx xxxxx xx všech xxxxxxxxx x xxx xxxxxxxxx xxxxxxxxxxx, xxxxx xxx xxxxx xxxxxxxxxx xxxxxxxxxx metody (např. XXXX) xxxxxxxx, že xx Xxxxxxxx látka xxxxxxxxxx xxxxxx. V xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

Xxxx se xxxxxxx xxxxxxxx analýzy xxxxxxxx xxxxxxxxxxx xx xxxxxxx hodnot, které xx normálně xxxxxxxxx x xxxx x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxxxxx exogenní původ Xxxxxxxx xxxxx, ale xxxxxxxx xxxxxx xxxxxxx Xxxxxxxx xxxxx, xxxx xxxx. xxxxxxxxx x xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx xxxxxxx, nebo xxxx xxxxxxxxx xxxxxxxxx xxxxx X/X xxxxx než xxxxx (4) xx xxxxx (1) x xxxxx spolehlivá analytická xxxxxx (např. XXXX) xxxxxxxxxxx exogenní xxxxx xxxxx, xxxxxxx příslušná Xxxxxxxxxxxxx xxxxxxxxxx další xxxxxxx xxxxxxxxxx výsledků xxxxxxxxxx xxxxx nebo xxxxxxxxxx následných xxxxx.

Xx-xx xxxxxxxxxx xxxxxx xxxxx xxxxxxx, pak xxxxxxxx bude xxxxxxxxxx xxxxxx xxxx xxxxxxxxx x xx xxxx xxxxxxxxx. Pokud laboratoř xxxxxxx, za xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxxx nutné xxxxxxxx xxxxx xxxxxxx, x xxxx xx xxx xx xx, xx Xxxxxx obsahuje Xxxxxxxxx xxxxx. Pokud xxxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) x xxxxxx x xxxxxxxxx minimálně 3 xxxxxxxxx testy, bude xxxxxxx xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx xxx, že xxxx xxxxxxxxxx Xxxxxxxxxxxxxx xxxxxxxxxx v xxxxxxxxxxxxx 3 měsících xxxxxxx xxxxxxxx bez xxxxxxxxxxx xxxxxxxx. Výsledek, xxxxx xxxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxx, bude hlášen xxxx xxxxxxxxx. Xxxxx xxxxxxxxxxxxxx profil Xxxxxxxxx, xxxxxxxx xxxxxxxxxx xxxxx, xxxx fyziologicky xxxxxxxx, xxxx xx xxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx nález.

X xxxxxxxx vzácných xxxxxxxxxxxxxx xxxxxxxxx xxxx xxx x moči xxxxxx xxxxxxx xxxxxxxx endogenního xxxxxx xx xxxxxx xxxxxx koncentracích (xx/xx). Xxxxx xxxxxxxxx takový xxxxx nahlásila x xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxxxxx exogenní původ Xxxxxxxx látky, může xxx xxxxxxxxx další xxxxxxx provedením xxxxxxxxxx xxxxx (xxxxxxxxxx xxxxx).

Xxxxx xxxxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx nález 19-xxxxxxxxxxxxxxx, xxxx xx xx xxxxxxxxx za xxxxxxx x xxxxxxxxxxx xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx xxxxx. X xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

X xxxxxxx, xx Xxxxxxxxx nebude xxxxxxxxxxxxx xxx xxxxxxx xxxxxxxxx, bude se xxx za to, xx Vzorek Sportovce xxxxxxxx Zakázanou xxxxx.

2. Xxxxxxx xxxxxxxxxx xxxxx, zahrnující:

Klenbuterol, xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (SARM), xxxxxxx, xxxxxxx, xxxxxxxxxx, ale xx x omezením xxxxx xx ně.

X2. XXXXXXX A XXXXXXXX XXXXX

Xxxxxxxxxxx xxxxx x xxxxxx xxxxxxxxxx xxxxxxx jsou xxxxxxxx:

1. Xxxxxxxxxxxx (EPO);

2. Xxxxxxx hormon (xXX), xxxxxxxx podobné xxxxxxx faktory (xxxx. XXX-1), xxxxxxxxxx xxxxxxx xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (např. XX, xXX), zakázané xxx x xxxx;

4. Xxxxxxxx;

5. Kortikotropiny

x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.

Pokud Xxxxxxxxx xxxxxx xxxxxxxx, xx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxxxxx xxxxxx, xxxx xx mít xx xx, xx Xxxxxx xxxxxxxx Zakázanou xxxxx (xxx xx uvedeno xxxx) x xxxxxxxxx, xxx koncentrace Zakázané xxxxx xxxx jejích xxxxxxxxxx xx indikátorů x/xxxx xxxxxxxxx xxxxxx xx Xxxxxx Xxxxxxxxx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxxx u xxxx xxx, že xxxxxxxxxxxx normální xxxxxxxxx xxxxxxxx.

Pokud laboratoř xxxxxxxxx, po xxxxx xxxxxxxxxx analytické metody, xx Xxxxxxxx xxxxx xx exogenního xxxxxx, xxxx xx xxx xx xx, že Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx a bude xxxxxxx Pozitivní xxxxxxxxxxx xxxxx.

X3. XXXX-2 XXXXXXXX

Xxxxxxx xxxx-2 xxxxxxxx včetně xxxxxx X- x X-xxxxxxx xxxx xxxxxxxx.

Xxxxxxxx jsou xxxxxxxxxx, xxxxxxxxxx, salmeterol a xxxxxxxxxx, xxx xxxxx xx xxx xxxxxxxx xxxxx xxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxxx.

I xxxx xxxx xxxxxxx xxxxxxxx forma terapeutické xxxxxxx, xxxx nález xxxxxxxxxxx (xxxxx xxxx xxxxxxxxxx) xxxxx než 1000 nanogramů v 1 xxxxxxxxx moči xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx nález, xxxxx Xxxxxxxxx xxxxxxxxx, že xxxxxxxxxx výsledek xxx xxxxxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxx v xxxxxxxx.

X4. ANTAGONISTÉ X XXXXXXXXXX HORMONŮ

Xxxxxxxxxxx xxxxxxx jsou xxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx receptorů (SERM), xxxxxxxx:

3. Xxxxxxx antiestrogenní xxxxx xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx funkce xxxxxxxxxx xxxxxx inhibitorů xxxxxxxxxx, xxx xx x omezením pouze xx xx.

X5. DIURETIKA X XXXXXXX XXXXXXXXX XXXXX

Xxxxxxxxx xxxxx xxxx xxxxxxxx. Xxxxxxxx:

Xxxxxxxxx*, xxxxxxxxxxxxxx, probenecid, xxxxxxxxxx alfa-reduktázy (xxxx. xxxxxxxxxx, xxxxxxxxxx), xxxxxxxxxxxxxxx (xxxx. albumin, xxxxxxx, xxxxxxxxxxxxxxxxx) a xxxxx xxxxx s podobnými xxxxxxxxxxxx xxxxxx.

Xxxxxxxxx xxxxxxxx:

Acetazolamid, amilorid, xxxxxxxxx, xxxxxxxxx, chlortalidon, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (xxxx. bendroflumethiazid, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), xxxxxxxxxx x xxxxx látky x xxxxxxxx chemickou xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx (kromě xxxxxxxxxxxx, xxxxx není xxxxxxxx).

* Xxxxxxxxxxxx xxxxxxx xxxx platná, xxxxx xxx Xxxxxxxxx xxxxxxxx diuretika xx xxxxxxx s xxxxxxxx xxxx xxxxxxxxxxx xxxxxxxx xxxx Zakázané xxxxx (xxxxx).

X1. ZVYŠOVÁNÍ PŘENOSU XXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

X2. XXXXXXXX X XXXXXXXXX XXXXXXXXXX

M3. XXXXXX XXXXXX

Xxxxxxxxxxxxxx xxxxxxx xxxxx, xxxx, xxxxxxxx xxxxxxxx, nebo xxxxxxxxxx xxxxxxx xxxx, xxxxx xxxx xxxxxxxxx xxxxxx sportovní xxxxx, xx zakázané.

X6. STIMULANCIA

Xxxxxxx xxxxxxxxxxx (xxxxxx xxxx xxxxxx xxxxxxxxxx xxxxxxxxx (X- x L-) xxxxxxx) jsou xxxxxxxx, x výjimkou xxxxxxxx xxxxxxxxx v xxxxxxx xxxxxx xxxxxxxx xxxxx x stimulancií xxxxxxxxxx xx Monitorovacího xxxxxxxx xxx xxx 2008.

Xxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx, xxxxxxxxx**, amfepramon, amfetaminil, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxxx****, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, fenproporex, xxxxxxxxx, 4-xxxxxxxxxxxxxx (xxxxxxxx), xxxxxxxxxx, heptaminol, xxxxxxxxxxxx, xxxxx***, xxxxxxxxxxx, xxxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, meklofenoxát, xxxxxxxxxxxx (D-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, niketamid, xxxxxxxxxxx, norfenfluramin, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, parahydroxyamfetamin, xxxxxxx, xxxxxxxxxxx, p-methylamfetamin, xxxxxxxxx, xxxxxxxxxxxxxx, selegilin, xxxxxxxxxx, strychnin, xxxxxxxxxxxxx x xxxxx látky x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx výslovně xxxx xxxxxxxx v xxxxx oddíle xxxx xxxxxxxxxx xx xxxxxxxxxxx xxxxx xxxxx, xxxxx Xxxxxxxxx xxxxxxx, že xxxx všeobecná xxxxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx umožňuje neúmyslné xxxxxxxx antidopingových pravidel, xxxx xx x xxx xxxxx xxxxxxxxxxxxxxx, xx bude xxxxxxx xxxxxxxx jako xxxxxxxxx xxxxx.

S7. XXXXXXXXX

Xxxxxxxxxxx xxxxxxxxx xxxx xxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), fentanyl x jeho xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, xxxxxxxxx, pentazocin, xxxxxxx.

X8. XXXXXXXXXXX

Kanabinoidy (xxxx. xxxxx, marihuana) jsou xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxx, xxxxxxxx, xxxxxxxxxx nebo xxxxxxxxxxxxx xxxxxxxx xxxx zakázané. Xxxxxx užití xxxxxxxx xxxxxxxxxxxxx xxxxxxx.

Xxxx xxxxxxx xxxxxxxx xxxxxxxx (xxxxxxxxxxxx, xx xxxxx xxxxxx, xx xxxxx xxxxxx, xxxxxxxxxx, xx xxxx) x xxxxxxxxx xxxxxxxx vyžadují zkrácenou xxxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxx uvedených.

Xxxxxxx xxxxxxxxx podávané xx xxxxxx xxxxx (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), xxxx, xxxxx, oční, xxxxxx xxxxx xxxxxxx xxxxxx, xxxxxxxx úst a xxxxx xxxxxx xxxxxxxx x nevyžadují xxxxxx xxxxx xxxxxxxxxxxx xxxxxxx.

X1. XXXXXXX

Xxxxxxx (xxxxxx) xx xxxxxxxx pouze Xxx xxxxxxx x xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx xxxx xxxxxxxx xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx xxxx. Xxxxxxx xxxxxxx pro xxxxxxxx xxxxxxxxxxx pravidla (xxxxxxxxxxxxx xxxxxxx) xx xxx xxxxxx xxxxxxxx uvedena x závorkách.

∙ Xxxxxxxxxxxx xxxxx (XXX) (0.10 g/l)

∙ Xxxxxx (WKF) (0.10 x/x)

∙ Xxxxxxx xxxxxx x xxxxxxxxxxxx (XXX) (0.20 x/x)

∙ Xxxxxxxxxxx (XXXX, XXX) (0.10 x/x)

∙ Moderní pětiboj (XXXX) xxx xxx xxxxxxxxxx xx xxxxxxxx (0.10 x/x)

∙ Xxxxxxxxxxx xxxxx (XXX) (0.10 x/x)

∙ Xxxxx xxxxxxxxxx (XXX) (0.30 x/x)

∙ Xxxxxxx (XXX) (0.10 g/l)

X2. XXXX-XXXXXXXXX

Pokud xxxx xxxxx xxxxxx, xxxx-xxxxxxxxx xxxx xxxxxxxx xxxxx Při soutěži x následujících xxxxxxxx.

∙ Xxxxxxxxxxxx sport (XXX)

∙ Xxxxxxxx (XXXX)

∙ Boby (XXXX)

∙ Xxxxx (XXX)

∙ Curling (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Jachting (XXXX) - "xxxxx xxxx" - jen xxxxxxxxxxx

∙ Kuželky (XXX)

∙ Letecké xxxxxx x xxxxxxxxxxxx (XXX)

∙ Xxxxxxxxxxx (XXXX, XXX) (zakázané xxxx Mimo xxxxxx)

∙ Xxxxxxxx (FIS) - xxxxx xx xxxxxx a akrobatické xxxxxxxx-xxxxx a U-rampa, x xxxxxxxxx X-xxxxx x "xxx xxx"

∙ Moderní xxxxxxx (XXXX) - jen xxxxxxxxxx se xxxxxxxx

∙ Xxxxxxxxxxx xxxxx (XXX)

∙ Petanque x xxxxxxx xxxxxx (XXXX, XXX "xxxxx")

∙ Střelba (XXXX, XXX) (xxxxxxxx xxxx Xxxx xxxxxx)

∙ Xxxxx xxxxxxxxxx (XXX)

∙ Xxxxx (XXXX)

Xxxx-xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx:

Xxxxxxxxxx, alprenolol, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx, celiprolol, xxxxxxx, xxxxxxxxx, karvedilol, labetalol, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, oxprenolol, pindolol, xxxxxxxxxxx, xxxxxxx, timolol, xxx xx s xxxxxxxx xxxxx na xx

"Xxxxxxxxxx xxxxx"* xxxx xxxxxxxxxxx xxxx:

∙ Xxxxxxx Xxxx-2 xxxxxxxx x xxxxxxxx, xxxxx salbutamolu (xxxxxxx xxxx glukuronidu) xxx xxxxxxxx xxxxxx xxx 1000 ng/ml xxxx x xxxxxxxxxxxx (xxxxxxx xx xxxxxxx S 1.2 Xxxxxxx anabolické xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, xxxxxxxxxxx, krotetamid, xxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, meklofenoxát, p-metylamfetamin, xxxxxxxxxxxx, niketamid, norfenefrin, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxx x všechna xxxxxxx stimulancia xxxxxxxxx xxxxxxxx x oddíle X6, xxx xxxxx Xxxxxxxxx xxxxxxx, že xxxxxxx podmínky xxxxxxx x xxxxxx X6;

∙ Xxxxxxxxxxx;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"X Seznamu xxxxx xxx xxxxxxxxxxx xxxxxxxxxx látky, které xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx antidopingových xxxxxxxx, xxxxxxx xxxx xxxxxxxxx xxxxxxxx v běžných xxxxxxxxx přípravcích, nebo x xxxxx xx xxxxx xxxxxxxxxxxxxxx, xx xxxxx xxxxxxx xxxxxxxx xxxx xxxxxxxxx činidla." Xxxxxxxx antidopingového pravidla xxxxxxxxxx takovéto xxxxx xxxx xxxxxxxx snížený xxxxxx za xxxxxxxxxxx, xx "...Xxxxxxxxx xxxx xxxxx xxxxxxxx, že Xxxxxxx xxxxxxxxxx xxxxx xxxxxx xxxxxxxxx xx xxxxxxx xxxxxxxxxxx xxxxxx...".

Xxxxxx xxxxxxx x. 2/2008 Xx. x. x. xxxxx účinnosti xxxx 31.1.2008.

Xxxxxx xxxxxxx x. 2/2008 Xx. m. x. xxx zrušen xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x xxxxxxxxx xx 7.2.2009.

Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx právních předpisů x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx derogační xxxxx xxxxx uvedeného xxxxxxxx předpisu.